BPTS Biophytis SA ADRs

Biophytis is a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, with a primary focus on neuromuscular diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol FP:ALBPS.

$16.50  +0.07 (0.43%)
As of 02/26/2021 10:57:53 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
ADRs
Micro cap
Health Care
Biotechnology
France

02/10/2021
1,200,000
23,589
$19,800,000
0.00%
SEC Edgar Online
20-F



Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
0.00
0.00
0.00%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy